Terms: = Breast cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Staging
3 results:
1. Role of interleukin-2 (il-2) in cancer-related immune deficiency: in vitro response to il-2, production of il-2, and il-2 receptor expression in patients with advanced cancer.
Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
Cancer Detect Prev; 1988; 12(1-6):149-59. PubMed ID: 3263194
[TBL] [Abstract] [Full Text] [Related]
2. Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients.
Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
Diagn Clin Immunol; 1987; 5(2):104-11. PubMed ID: 3497733
[TBL] [Abstract] [Full Text] [Related]
3. Peripheral blood lymphocyte response to exogenous interleukin 2 by PHA-prestimulated and non-PHA-prestimulated cells in patients with cancer.
Mantovani G; Coiana A; Cossu F; Floris C; Proto E; Macciò A; Pisano G; Taglieri G; Puxeddu G; Del Giacco GS
Tumori; 1986 Aug; 72(4):375-82. PubMed ID: 3490027
[TBL] [Abstract] [Full Text] [Related]
